Important News & Announcements

Stay up to date with the latest news and announcements from NASCSA.

VA Inspector General Report Finds Majority of Physicians Not Reported to State Licensing Boards

Posted 4/13/2022

A new report issued on April 7, 2022 by the Veterans Administration Inspector General's Office has found that the Veteran's Administration failed to consistently notify state medical boards when department physicians are fired for malpractice or incompetence, a situation that could put...
Read More

FDA and DEA Warn Online Pharmacies Illegally Selling Adderall to Consumers

Posted 4/12/2022

The U.S. Food and Drug Administration and the U.S. Drug Enforcement Administration recently issued joint warning letters to operators of two websites illegally selling Schedule II stimulants, including amphetamine drug products marketed as Adderall. These websites sell Adderall online without a...
Read More

DEA To Issue Final Rule on New/Renewal Applications to be Submitted Online

Posted 4/10/2022

On April 11, 2022, the Drug Enforcement Administration (DEA) will publish a Final Rule in the Federal Register to amend its regulations to require all new and renewal applications for DEA registration to be submitted only through a secure online portal. The Rule becomes effective 30 days after...
Read More

Former state health department official hired to oversee creation of Missouri's PDMP Program

Posted 4/8/2022

A Missouri task force assigned with overseeing the creation of a statewide prescription drug monitoring program has hired a former state health department veteran to serve as the program?s executive director.

Dean Linneman, the former director of the Department of Health and Senior...
Read More

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

Posted 4/7/2022

WASHINGTON, DC ? Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA?s Public Safety Alert, the first in six...
Read More

NASCSA Surveys Its Members on gabapentin and gabapentin enacarbil

Posted 4/3/2022

In March of 2022 NASCSA conducted a survey of it?s state members requesting their input on a recent petition submitted Public Citizen to the FDA and DEA to place gabapentin and gabapentin enacarbil on schedule V of the Controlled Substances Act. Attached please find the results of the survey...
Read More

Alaska Senate Passes Bill Exempting Veterinarians from Controlled Substance Database

Posted 4/1/2022

Senate Bill 132 passed the Senate by a vote of 16-0 and is now on its way to the Alaska House of Representatives for consideration. For more information, please contact the Senate Majority Press office at (907) 465-4066.

Prescription Drug Monitoring Programs are designed for use in human...
Read More

State Laws Had Little Impact on Opioid Prescribing

Posted 3/19/2022

Another study that finds increase in drug overdoses after state implements PDMP reporting.

Note:  It's important to read and understand the studies.  Authors providing news/summaries may inject personal bias or have other motives.  Like with everything you...
Read More

President Biden Signs the Methamphetamine Response Act of 2021

Posted 3/15/2022

On Monday, March 14, 2022, President Biden signed into law S. 854, the Methamphetamine Response Act of 2021, which designates methamphetamine as an emerging drug threat and requires the Office of National Drug...
Read More

NIH Workshop on Psychedelics as Therapeutics

Posted 2/26/2022

The NIH Workshop on Psychedelics as Therapeutics was conducted earlier this year by the National Institute of Mental Health, the National Institute on Drug Abuse, and the National...
Read More

View Earlier Announcements

Sponsor Spotlight


RxGov by Tyler Technologies
RxGov is a leading Prescription Monitoring Platform (PMP) that improves access to clinical data pertinent to a patient's medication history and the risk factors associated with substance use disorder through the capture, analysis, proactive monitoring, and open sharing of a state's prescription dispense details.

The system is one of the most interoperable, integrated and intuitive on the market. It also includes complete oversight and compliance with the state's current PDMP system, including statewide mandates. RxGov allows the PDMP administrator unprecedented access to insightful data sets, such as query history and compliance reports at all levels: state, region, organization, and individual prescriber. Freely accessible data, enhanced by useful visualization tools, is central to RxGov.

To learn more about RxGov and how the platform can help state governments fight the opioid crisis, email rxgov@egov.com or download our one pager.

All Sponsors